“Bladder Cancer Diagnosis and Monitoring Based on Urine Survivin (BIRC5) Bioluminescence-Based Immunoassay”, Вопр. онкол., vol. 72, no. 2, p. OF-2510, May 2026, doi: 10.37469/0507-3758-2026-72-2-OF-2510.